ArticleBiologics : targets & therapy2021

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population.

Julia Berman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.